Polygenic Risk Scores May Improve IBD Risk Prediction
MONDAY, Jan. 4, 2021 -- Risk scores from multiethnic populations improve risk prediction for inflammatory bowel disease (IBD), according to a study published online Dec. 24 in Gastroenterology.
Kyle Gettler, Ph.D., from the Icahn School of Medicine at Mount Sinai in New York City, and colleagues examined the effects of common and rare IBD variants on disease prediction and pathophysiology using exome-sequence and single-nucleotide polymorphism array data from 29,358 individuals in the multiethnic BioMe biobank. Polygenic risk scores (PRS) were calculated from European, African American, and Ashkenazi Jewish reference case-control studies; all three datasets were used to run a meta-genomewide association study. PRS were then combined to examine which combination of scores best predicted IBD status.
The researchers found that for every population in BioMe, combining risk scores based on association data from distinct ancestral populations improved IBD prediction; among individuals of European ancestry in the U.K. Biobank, prediction was significantly improved. For non-Europeans, lower predictive power was observed, partly due to lower African IBD case-control reference sizes. Associations for two very early-onset IBD genes, ADAM17 and LRBA, were replicated, with high dominant model penetrance in BioMe. There was an association for autosomal, recessive LRBA risk alleles with severe, early-onset autoimmunity.
"The ability to accurately predict genetic disease risk in individuals across ancestries is a critical avenue that may positively affect patient outcomes, as early interventions and even preventive measures are being considered and developed," a coauthor said in a statement. "These findings support a need for greater genetic diversity, including more data on African American populations, to enhance disease risk predictions and reduce health disparities for all populations."
One author disclosed financial ties to the biotechnology industry.
© 2021 HealthDay. All rights reserved.
Posted: January 2021
Read this next
THURSDAY, Dec. 17, 2020 -- Lower socioeconomic status (LSS) is associated with worse outcomes for inflammatory bowel disease (IBD), according to a study published in the December...
MONDAY, Nov. 9, 2020 -- Life expectancy has increased for individuals with inflammatory bowel disease (IBD), but there is still a gap in life expectancy for those with and without...
WEDNESDAY, Oct. 28, 2020 -- Patients with inflammatory bowel disease (IBD) report concern about the impact of COVID-19 on their health, and many perceive themselves as being at...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.